Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1230
-0.0070 (-5.38%)
Apr 2, 2026, 3:59 PM HKT
Market Cap206.39M -15.8%
Revenue (ttm)1.08B -6.7%
Net Income-45.33M
EPS-0.03
Shares Out1.68B
PE Ration/a
Forward PEn/a
Dividend0.01 (4.10%)
Ex-Dividend Daten/a
Volume380,000
Average Volume298,000
Open0.1220
Previous Close0.1300
Day's Range0.1210 - 0.1290
52-Week Range0.1210 - 0.3800
Beta-0.30
RSI23.77
Earnings DateMar 25, 2026

About HKG:8329

Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China. The company offers medicines for various therapeutic areas, including oncology, cardiovascular system, respiratory system, digestive system, and mental disorders. It also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology busine... [Read more]

Sector Healthcare
Founded 2002
Employees 1,474
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 8329
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements